Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management (An Externally Controlled Pilot Trial)

NCT04343092 is registered in ClinicalTrials.gov with University of Baghdad as lead sponsor.

NCT NCT04343092
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04343092 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management (An Externally Controlled Pilot Trial)
Lead sponsor
University of Baghdad
Phase
Phase 1
Overall status
Completed
Start date
April 18, 2020
Completion date
June 1, 2020
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid 19